Tate & Lyle PLC — Share Issue/Capital Change 2022

Jul 1, 2022

National Storage Mechanism | Additional information

RNS Number : 0075R

Tate & Lyle PLC

01 July 2022

BLOCK LISTING SIX MONTHLY RETURN

Date: 1 July 2022

Name of applicant:		TATE & LYLE PLC
Name of scheme:		TATE & LYLE SHARESAVE PLAN
Period of return:	From:	1 JANUARY 2022	To:	30 JUNE 2022
Balance of unallotted securities under scheme(s) from previous return:		183,507
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		41,671
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		141,836
Total number of shares in issue at the end of the period:		401,609,061

NOTES	Tate & Lyle underwent a consolidation of share capital on 3 May 2022 on the basis of 6 new ordinary shares of 29 1/6 pence nominal capital for every 7 existing ordinary shares of 25 pence nominal capital held. The opening balance together with the number of shares issued under the blocklisting up to 2 May 2022 have been adjusted to reflect the post-consolidation (i.e. current) share capital of the Company, and include a balancing allotment of 3 existing ordinary shares taken from the blocklisting for this purpose.
Name of contact:	CLAIRE-MARIE O'GRADY, COMPANY SECRETARY
Telephone number of contact:	020 7257 2100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRSSDSUFEESEEW